Published in
Wiley, International Journal of Cancer, 8(146), p. 2348-2359, 2019
DOI: 10.1002/ijc.32668
Links
Tools
IGF‐1R pathway activation as putative biomarker for linsitinib therapy to revert tamoxifen resistance in ER‐positive breast cancer
Journal article published in 2019 by
Dinja T. Kruger 
,
Xanthippi Alexi,
Mark Opdam,
Karianne Schuurman,
Leonie Voorwerk,
Joyce Sanders,
Vincent Noort,
Epie Boven,
Wilbert Zwart ,
Sabine C. Linn
,
Xanthippi Alexi,
Mark Opdam,
Karianne Schuurman,
Leonie Voorwerk,
Joyce Sanders,
Vincent Noort,
Epie Boven,
Wilbert Zwart ,
Sabine C. Linn
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 